약동학 서비스 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 약물 유형별, 용도별, 최종 용도별, 지역별, 경쟁별(2020-2030년)
Pharmacokinetics Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type, By Application, By End-use, by region, and Competition, 2020-2030F
상품코드:1881572
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 182 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 약동학 서비스 시장은 2024년에 10억 7,436만 달러로 평가되었으며, 2030년까지 CAGR 8.2%로 성장하여 17억 2,391만 달러에 달할 것으로 예측됩니다.
약동학(PK) 서비스는 생물학적 시스템 내에서 약물의 흡수, 분포, 대사 및 배설(ADME)에 대한 과학적 분석을 포함하며, 치료 용량을 최적화하고 약효를 향상시키며 전임상 및 임상 개발 단계에서 규제 준수를 보장하는 데 매우 중요한 역할을 합니다. 이러한 필수 서비스 시장은 주로 세계 제약 R&D 투자 증가, 생물학적 제제를 포함한 신약의 복잡성 증가, 맞춤형 의료 전략에 대한 관심 확대에 의해 주도되고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
10억 7,436만 달러
시장 규모 : 2030년
17억 2,391만 달러
CAGR : 2025-2030년
8.2%
가장 빠르게 성장하는 부문
바이오테크놀러지 및 제약 기업
최대 시장
북미
주요 시장 촉진요인
세계 약동학 서비스 시장은 의약품 개발의 복잡성과 바이오의약품의 수요 증가로 인해 크게 견인되고 있습니다. 현대의 의약품 개발은 특히 희귀질환 및 맞춤의료에서 복잡한 신규 분자를 타겟으로 하는 경향이 강화되고 있으며, 고도로 전문화된 약동학 분석이 요구되고 있습니다.
주요 시장 과제
고도의 약동학(PK) 시험 수행에 따른 막대한 비용과 고유한 복잡성은 세계 약동학 서비스 시장 성장에 큰 장벽으로 작용하고 있습니다. 특히 복잡한 생물학적 제제나 맞춤형 치료제의 경우, 이러한 시험에 필요한 전문 장비, 고도로 숙련된 인력, 그리고 광범위한 검증은 상당한 재정적 지출로 이어집니다.
주요 시장 동향
인공지능(AI)과 머신러닝을 약동학 모델링에 통합하는 움직임은 효율성과 예측 정확도를 향상시켜 의약품 개발을 재구성하는 중요한 추세입니다. 이러한 고도의 계산 기법을 통해 방대한 데이터셋을 처리할 수 있어 기존 방법보다 높은 정확도로 약물의 흡수, 분포, 대사, 배설(ADME) 특성 예측 정확도가 향상됩니다.
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 약동학 서비스 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
약물 유형별(저분자, 고분자)
용도별(중소기업, 대기업)
최종 용도별(바이오테크놀러지·제약 기업, 학술·정부 조사기관, 기타)
지역별
기업별(2024)
시장 맵
제6장 북미의 약동학 서비스 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 약동학 서비스 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 약동학 서비스 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 약동학 서비스 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 약동학 서비스 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병
제품 출시
최근 동향
제13장 세계의 약동학 서비스 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
Evotec AG
Certara, L.P.
Pacific BioLabs
GVK Biosciences Private Limited
Shanghai Medicilon Inc.
Pharmaceutical Product Development, LLC
Charles River Laboratories International, Inc.
PAREXEL International Corporation
Eurofins Scientific SE
Frontage Labs
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
KSM
영문 목차
영문목차
The Global Pharmacokinetics Services Market, valued at USD 1074.36 Million in 2024, is projected to experience a CAGR of 8.2% to reach USD 1723.91 Million by 2030. Pharmacokinetics (PK) services encompass the scientific analysis of drug absorption, distribution, metabolism, and excretion (ADME) within biological systems, playing a pivotal role in optimizing therapeutic dosages, enhancing drug efficacy, and ensuring regulatory compliance throughout preclinical and clinical development. The market for these essential services is primarily propelled by increasing global pharmaceutical research and development investments, the rising complexity of novel drug entities including biologics, and the expanding focus on personalized medicine strategies.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 1074.36 Million
Market Size 2030
USD 1723.91 Million
CAGR 2025-2030
8.2%
Fastest Growing Segment
Biotechnology and Pharmaceutical Companies
Largest Market
North America
Key Market Drivers
The global pharmacokinetics services market is significantly driven by the rising complexity of drug development and the increasing demand for biopharmaceuticals. Modern drug development increasingly targets intricate novel entities, especially for rare diseases and personalized medicine, which necessitates highly specialized pharmacokinetic analysis. This heightened complexity demands sophisticated study designs and advanced analytical techniques to understand drug behavior in diverse patient populations. According to a research article in the British Journal of Pharmacology, in March 2024, "Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review," over half of the seventy novel drugs authorized in 2023 targeted rare diseases or intractable forms of cancer, underscoring this industry shift towards challenging therapeutic areas.
Key Market Challenges
The substantial costs and inherent complexities associated with conducting advanced pharmacokinetic (PK) studies present a significant impediment to the growth of the Global Pharmacokinetics Services Market. The specialized equipment, highly skilled personnel, and extensive validation required for these studies, particularly for complex biologics and personalized therapies, translate into considerable financial outlays. This financial burden can restrict the number of drug candidates that companies, especially smaller biotechnology firms, can advance into development, thereby limiting the overall demand for PK services.
Key Market Trends
The integration of Artificial Intelligence and Machine Learning into pharmacokinetic modeling represents a pivotal trend reshaping drug development by enhancing efficiency and predictive accuracy. These advanced computational methods enable the processing of extensive datasets, improving the prediction of drug absorption, distribution, metabolism, and excretion (ADME) properties with greater precision than traditional approaches. According to a December 2023 survey by Rackspace Technology and Dell/VMware, 68% of pharmaceutical businesses identified pervasive AI as having the highest potential impact on their business, indicating a strong industry recognition of this technology's transformative power. This integration allows for more informed decision-making earlier in the development pipeline, potentially reducing the need for costly in vivo experiments and accelerating the identification of promising drug candidates.
Key Market Players
Evotec AG
Certara, L.P.
Pacific BioLabs
GVK Biosciences Private Limited
Shanghai Medicilon Inc.
Pharmaceutical Product Development, LLC
Charles River Laboratories International, Inc.
PAREXEL International Corporation
Eurofins Scientific SE
Frontage Labs
Report Scope:
In this report, the Global Pharmacokinetics Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Pharmacokinetics Services Market, By Drug Type:
Small Molecules
Large Molecules
Pharmacokinetics Services Market, By Application:
Small and Medium Enterprise
Large Enterprise
Pharmacokinetics Services Market, By End-Use:
Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Others
Pharmacokinetics Services Market, By Region:
North America
Europe
Asia Pacific
South America
MEA
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Pharmacokinetics Services Market.
Available Customizations:
Global Pharmacokinetics Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Pharmacokinetics Services Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drug Type (Small Molecules, Large Molecules)
5.2.2. By Application (Small and Medium Enterprise, Large Enterprise)
5.2.3. By End-Use (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Pharmacokinetics Services Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Type
6.2.2. By Application
6.2.3. By End-Use
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Pharmacokinetics Services Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Drug Type
6.3.1.2.2. By Application
6.3.1.2.3. By End-Use
6.3.2. Canada Pharmacokinetics Services Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Drug Type
6.3.2.2.2. By Application
6.3.2.2.3. By End-Use
6.3.3. Mexico Pharmacokinetics Services Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Drug Type
6.3.3.2.2. By Application
6.3.3.2.3. By End-Use
7. Europe Pharmacokinetics Services Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Type
7.2.2. By Application
7.2.3. By End-Use
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Pharmacokinetics Services Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Type
7.3.1.2.2. By Application
7.3.1.2.3. By End-Use
7.3.2. France Pharmacokinetics Services Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Type
7.3.2.2.2. By Application
7.3.2.2.3. By End-Use
7.3.3. United Kingdom Pharmacokinetics Services Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Type
7.3.3.2.2. By Application
7.3.3.2.3. By End-Use
7.3.4. Italy Pharmacokinetics Services Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Drug Type
7.3.4.2.2. By Application
7.3.4.2.3. By End-Use
7.3.5. Spain Pharmacokinetics Services Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Drug Type
7.3.5.2.2. By Application
7.3.5.2.3. By End-Use
8. Asia Pacific Pharmacokinetics Services Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Type
8.2.2. By Application
8.2.3. By End-Use
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Pharmacokinetics Services Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Type
8.3.1.2.2. By Application
8.3.1.2.3. By End-Use
8.3.2. India Pharmacokinetics Services Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Type
8.3.2.2.2. By Application
8.3.2.2.3. By End-Use
8.3.3. Japan Pharmacokinetics Services Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Type
8.3.3.2.2. By Application
8.3.3.2.3. By End-Use
8.3.4. South Korea Pharmacokinetics Services Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drug Type
8.3.4.2.2. By Application
8.3.4.2.3. By End-Use
8.3.5. Australia Pharmacokinetics Services Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drug Type
8.3.5.2.2. By Application
8.3.5.2.3. By End-Use
9. Middle East & Africa Pharmacokinetics Services Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Type
9.2.2. By Application
9.2.3. By End-Use
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Pharmacokinetics Services Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Type
9.3.1.2.2. By Application
9.3.1.2.3. By End-Use
9.3.2. UAE Pharmacokinetics Services Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Type
9.3.2.2.2. By Application
9.3.2.2.3. By End-Use
9.3.3. South Africa Pharmacokinetics Services Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Type
9.3.3.2.2. By Application
9.3.3.2.3. By End-Use
10. South America Pharmacokinetics Services Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Drug Type
10.2.2. By Application
10.2.3. By End-Use
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Pharmacokinetics Services Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drug Type
10.3.1.2.2. By Application
10.3.1.2.3. By End-Use
10.3.2. Colombia Pharmacokinetics Services Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Drug Type
10.3.2.2.2. By Application
10.3.2.2.3. By End-Use
10.3.3. Argentina Pharmacokinetics Services Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Drug Type
10.3.3.2.2. By Application
10.3.3.2.3. By End-Use
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Pharmacokinetics Services Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Evotec AG
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Certara, L.P.
15.3. Pacific BioLabs
15.4. GVK Biosciences Private Limited
15.5. Shanghai Medicilon Inc.
15.6. Pharmaceutical Product Development, LLC
15.7. Charles River Laboratories International, Inc.
